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Spontaneously Diabetic Torii-fa/fa (SDT fatty) rat is a new model of obese type 2 diabetes. SDT fatty rat exhibits obesity associated
with hyperphagia. In this study, SDT fatty rats were subjected to pair-feeding with SDT-+/+ (SDT) rats from 6 to 22 weeks of
age. The ratio of visceral fat weight to subcutaneous fat weight (V/S) decreased at 12 weeks of age in the pair-feeding rats. The
intraperitoneal fat weight such as epididymal and retroperitoneal fat weight decreased, whereas mesenteric fat weight had no
change. Cell size of the epididymal fat in the pair-feeding rats tended to decrease. Glucose oxidation level in epididymal fat in
the pair-feeding rats at 12 weeks of age was recovered to a similar level with that in SDT rats. These results indicated that SDT
fatty rat is a useful model to evaluate the functional or the morphological features in adipose tissue and develop a novel drug for
antiobesity.
Copyright © 2009 Hisayo Morinaga et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
Spontaneously Diabetic Torii (SDT) fatty rat is a new model
of obese type 2 diabetes, established by introducing the
fa allele of the Zucker fatty rat into the SDT rat genome
[1]. SDT rat is a useful model of nonobese type 2 diabetes
that spontaneously develops hyperglycemia and glucose
intolerance resulting from decreased insulin secretion due to
β-cell degeneration [2, 3]. It is worthy of notice that SDT
rat shows ocular complications such as venous dilation and
meandering vascular networks [4]. SDT fatty rat exhibited
hyperphagia and obesity immediately after weaning, and the
diabetes and its complications are found at a younger age in
SDT fatty rats than in SDT rats [5].
Obesity plays a key role in the pathophysiology of several
metabolic diseases and is a risk factor for diabetes mellitus or
dyslipidemia. It has been reported that the distribution of fat
between subcutaneous and visceral sites aﬀects its metabolic
impact. Speciﬁcally, increased abdominal adiposity has been
identiﬁed as a risk factor for diabetes mellitus [6–9]. Aging
in rats is associated with increased fasting and postprandial
plasma insulin levels, suggesting an insulin-resistant state.
The insulin resistance has a correlation with increase of fat
weight, especially visceral fat [10, 11]. Food intake in SDT
fatty rats at 6 weeks of age showed about twofold increase as
comparedwiththatinSDTrats,andbodymassindexandfat
pad weight in SDT fatty rats at 14 weeks of age increased [1].
In SDT fatty rat, which shows hyperphagia and obesity, it is
essential that the relationships of the changes between food
intakeandfattissueareexaminedindetail.Thepresentstudy
was conducted to investigate how food restriction in SDT
fatty rats aﬀects fat weight, fat mass, or metabolic function
of adipose tissue.
2.MaterialsandMethods
2.1. Animals and Diet. This experiment was conducted in
compliance with the Guidelines for Animal Experimentation2 Experimental Diabetes Research
of Japan Tobacco biological/pharmacological research labo-
ratories. Male SDT-fa/fa (SDT fatty) rats and age-matched
SDT-+/+ (SDT) rats from our colonies were used. SDT
fatty rats at 6 weeks of age were divided into two groups.
One group was allowed feed (CRF-1, Charles River Japan,
Yokohama, Japan) ad libitum, and the other group was pair-
fedthesameamountoffoodconsumedbyage-matchedSDT
r a t sf r o m6t o2 2w e e k so fa g e .F o o dc o n s u m p t i o ni nt h e
pair-fed SDT fatty rats was about 50%–60% of that in the ad
libitum-fed SDT fatty rats during the experimental period.
In brief, three groups of rat at 6 weeks of age were prepared:
(a) SDT fatty rats fed ad libitum (Fatty Group), (b) SDT fatty
rats pair-fed against SDT rats (Fatty-PF Group), and (c) SDT
rats fed ad libitum (SDT Group). A satellite group of each
of the three groups was established to evaluate additional
eﬀects to 12 weeks of age. The rats were housed individually
insuspendedbracketcagesinaclimate-controlledroomwith
at e m p e r a t u r eo f2 3± 3◦C, humidity of 55 ± 1 5 % ,a n da1 2
hours lighting cycle and had free access to water.
2.2. Biological Parameters. Body weights and blood chemical
parameters, such as glucose, triglyceride (TG), insulin,
leptin, and adiponectin levels, were measured at 6, 12, and
22 weeks of age.
Blood samples were collected from the tail vein of
rats. Serum glucose and TG levels were measured using
commercial kits (Roche Diagnostics, Basel, Switzerland)
and an automatic analyzer (Hitachi 7180; Hitachi, Tokyo,
Japan). Serum insulin or leptin levels were measured with
a rat insulin- or leptin enzyme-linked immunosorbent
assay (ELISA) kit (Morinaga Institute of Biological Science,
Yokohama, Japan). Serum adiponectin was measured with
a mouse/rat adiponectin ELISA kit (Otsuka pharmaceutical
Inc., Tokyo, Japan).
2.3.FatTissueWeight. Visceralandsubcutaneousfatweights
in each rat were determined at 6, 12, and 22 weeks of age
by computed tomography (CT) analysis. The fat weights
were measured by a laboratory X-ray CT device (LATheta,
ALOKA Co., LTD., Osaka, Japan). Rats were anesthetized
with an intraperitoneal injection of 50mg/kg pentobarbital
(Tokyo chemical industry, Tokyo, Japan), and about 20 CT
photographs per rat were taken at 5mm intervals between
diaphragm and lumbar vertebrae. The ratio of Visceral and
Subcutaneous (V/S) were calculated.
Necropsywasperformedinsatellitegroupsat12weeksof
age, and weights of intraperitoneal fat, such as epididymal,
retroperitoneal, and mesenteric fat, were determined. Rats
were sacriﬁced by exsanguination under light ether anes-
thesia, and intraperitoneal fats were collected and weighed.
Epididymal fats obtained in this necropsy were used in
evaluationoffatcellsizeandinglucoseoxidationandmRNA
expressionexperiments.Sinceasuﬃcientfatamountiseasily
collected, epididymal fats were used in those experiments.
2.4. Fat Cell Size. Cell size of epididymal fat was determined
a t1 2w e e k so fa g e .C e l ln u m b e ro fﬁ x e dv i e wa r e aw a s
counted for 3 diﬀerent areas per rat. Cells with incomplete
shape on the view frame were not counted. Cells size was
estimated as the ﬁxed area divided by the cell number.
2.5. Glucose Oxidation. Glucose oxidation levels on epididy-
mal fat were determined at 12 weeks of age. Adipose tissue
samples were incubated in Hanks’ balanced salt solution (pH
7.4, GIBCO, Grand Island, NY, USA) containing 4% BSA
(bovine serum albumin, Sigma Chemical, St. Louis, MO,
USA), 20.72kBq/mL [U]-14C-glucose (NEN, Boston, MA,
USA), and 0–100mU/mL insulin (from bovine pancreas,
Sigma) for 120 minutes at 37◦C. Synthesized 14CO2 was
trapped with Scintilamine-OH (Dojindo, Tokyo, Japan) on a
ﬁlter paper (Whatman, Maidstone, UK) and counted using
a Liquid Scintillation Analyzer Model 2500 TR (Packard,
Meriden, CT, USA). Total lipid synthesis from glucose was
estimated by determining the amount of 14C incorporated
into total lipids. Total lipids were extracted from the tissues
with n-hexane after the addition of Dole’s solution (2-
propanol : n-heptane : 1 N H2SO4 = 40 : 10 : 1).
Radioactivity in the hexane fractions was measured using a
liquid scintillation counter.
2.6. mRNA Quantiﬁcation with Real-Time Quantitative
PCR. Total RNA was extracted from the epididymal fat
of the satellite group rats at 12 weeks of age. RNA was
transcribed into cDNA using M-MLV reverse transcriptase
and random primers (Invitrogen, Carlsbad, CA, USA).
The reaction mixture was incubated for 10 minutes at
25◦C ,1h o u ra t3 7 ◦C, and 5 minutes at 95◦C. Real time
PCR quantiﬁcation was performed in a 50μLr e a c t i o n
mixture with an automated sequence detector combined
with ABI Prism 7700 Sequence Detection System software
(Applied Biosystems, Foster City, CA, USA). The reaction
mixture contained 50ng of synthesized cDNA, 3.5mM
MgCl2,0 . 3 μMp r i m e r s ,0 . 1 μM probes, and 1.25 units of
Ampli Taq Gold. Cycle parameters were 10 minutes at
95◦C, followed by 40 cycles of 15 seconds at 95◦Ca n d
60 seconds at 60◦C. The following primers and FAM-
conjugated probes were designed using Primer Express
software (Applied Biosystems): glucose transporter 4
(GLUT4) (forward, CTACATCCGAACCTGGAG; reverse,
AGTGCATCAGACACATCAGCCC; probe, TGCCCGAAA
GAGTCTAAAGCG), tumor necrosis factor α (TNFα)
(forward, CCAGGTTCTCTTCAAGGGACAA; reverse,
CTCCTGGTATGAAATGGCAAATC; probe, CCCGAC-
TATGTGTGCTCCTCACCCACA), lipoprotein lipase (LPL)
(forward, TGTCTAACTGCCACTTCAACCACA; reverse,
CATACATTCCTGTCACCGTCCA; probe, CAGCAAAAC
CTTTGTGGTGATCCATGG), Acetyl CoA carboxylase 1
(ACC-1) (forward, GCAGCTATGTTCAGAGAGTTCACC;
reverse, CCACCTCACAGTTGACTTGTTTTC; probe,
CGGCGACTTACGTTCCTAGTTGCACAAAA) and 18
seconds rRNA (purchased from Applied Biosystems).
2.7. Statistical Analyses. Results are expressed as the mean
± standard deviation (SD). Statistical analysis of diﬀerences
between mean values was performed using the F-test,Experimental Diabetes Research 3
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Figure 1: Changes in body weights (a) and serum parameters ((b) Glucose; (c) Triglyceride; (d) Insulin; (e) Leptin; (f) Adiponectin)
in Fatty rats, Fatty-PF rats, and SDT rats. Body weight in Fatty-PF rats showed similar change to that in SDT rats. Hyperglycemia and
hypertriglyceridemia in Fatty rats were temporally improved by food restriction, and the hyperinsulinemia was maintained to 12 weeks of
age. Serum leptin and adiponectin levels were elevated in the Fatty-PF rats. Data represent means ± SD (n = 5-6). ∗P<. 05, ∗∗P<. 01:
signiﬁcantly diﬀerent from SDT rat.
followed by the Student’s t-test or Aspin-Welch’s t-test.
Diﬀerences were deﬁned as signiﬁcant at P<. 05.
3. Results
3.1. Biological Parameters. Body weight in the SDT fatty rats
was already elevated as compared with that in the SDT rats
at the starting point of this experiment, 6 weeks of age (mean
value: SDT fatty rats, 207g; SDT rats, 174g). Body weight in
the Fatty Group showed a signiﬁcant increase at 12 weeks of
age as compared with that in the SDT Group, whereas body
weight in the Fatty-PF Group showed similar changes at 12
and 24 weeks of age to those in the SDT Group (Figure 1(a)).
Serum glucose level in the SDT fatty rats was already
elevated as compared with that in the SDT rats at 6 weeks4 Experimental Diabetes Research
Table 1: Changes of fat tissue weights in Fatty Group, Fatty-PF Group, and SDT Group. Visceral and subcutaneous fat tissue weights were
determined by computed tomography analysis. Data represent mean ± SD (n = 5-6).
6w e e k so fa g e 1 2w e e k so fa g e 2 2w e e k so fa g e
Fatty Group
Visceral fat (g) 9.8 ± 1.0 47.9 ± 1.9 85.9 ± 15.8
Subcutaneous fat (g) 16.3 ± 1.7 39.2 ± 10.9 51.6 ± 37.3
Total fat (g) 26.1 ± 2.4 87.1 ± 11.0 137.5 ± 52.5
V/S ratio 0.60 ± 0.07 1.29 ± 0.31 2.04 ± 0.66
Fatty-PF Group
Visceral fat (g) 10.5 ± 1.0 37.0 ± 1.4## 75.5 ± 2.5
Subcutaneous fat (g) 16.5 ± 1.9 50.8 ± 9.0 59.8 ± 8.8
Total fat (g) 27.1 ± 2.8 87.8 ± 9.2 135.2 ± 10.4
V/S ratio 0.64 ± 0.04 0.75 ± 0.15## 1.28 ± 0.19
SDT Group
Visceral fat (g) 2.9 ± 0.8 17.8 ± 2.8 27.1 ± 10.6
Subcutaneous fat (g) 2.2 ± 0.6 9.1 ± 2.3 13.5 ± 6.2
Total fat (g) 5.1 ± 1.4 26.9 ± 5.0 40.6 ± 16.7
V/S ratio 1.31 ± 0.07 2.01 ± 0.22 2.30 ± 0.89
##P<. 01: signiﬁcantly diﬀerent from Fatty Group.
of age (mean value: SDT fatty rats, 313mg/dL; SDT rats,
158mg/dL). Serum glucose level in the Fatty Group was
elevated to 600–700mg/dL at 12 and 22 weeks of age. Serum
glucose level in the Fatty-PF Group was suppressed to a
similar level as in the SDT Group at 12 weeks of age, whereas
the glucose level was elevated to about 550mg/dL at 22
weeks of age (Figure 1(b)). Hypertriglyceridemia in the Fatty
Group was sustained during the experimental period. Serum
TG level in the Fatty-PF Group tended to be decreased at 12
weeksofageascomparedwiththatintheFattyGroup(mean
value: Fatty-PF Group, 271mg/dL; Fatty Group, 548mg/dL;
see Figure 1(c)). Hyperinsulinemia in the Fatty Group was
shown at 6 weeks of age, whereas, after 12 weeks of age,
the insulin level decreased to a level similar to that in the
SDT Group (Figure 1(d)). Hyperinsulinemia in the Fatty-PF
Group was maintained until 12 weeks of age. Serum leptin
level in the SDT fatty rats was elevated as compared with
that in the SDT rats at 6 weeks of age (mean value: SDT
fatty rats, 10.0ng/mL; SDT rats, 2.2ng/mL). The elevation in
the Fatty-PF Group was sustained during the experimental
period (Figure 1(e)). Serum leptin level in the Fatty Group
also tended to increase. Serum adiponectin level in the Fatty-
PF Group was signiﬁcantly increased at 12 and 22 weeks of
age (Figure 1(f)). The adiponectin level in the Fatty Group
was signiﬁcantly increased at 22 weeks of age, but the level at
the starting point of this experiment tended to be increased
as compared with that in the SDT Group.
Food restriction in SDT fatty rats induced a temporal
improvement of hyperglycemia and an increase of serum
leptin and adiponectin level.
3.2. Fat Tissue Weight. At 6 weeks of age, total fat weight,
which is the sum of visceral fat weight and subcutaneous fat
weight, was about 5 times higher in the SDT fatty rats than
in the SDT rats. The fat weight in each group was elevated
with aging, from 6 to 22 weeks of age. The fat weights and
V/S ratios at 6 weeks of age were comparable in the Fatty
Group and the Fatty-PF Group. At 12 weeks of age, total fat
weights in both groups were at similar levels (mean value:
Fatty Group, 87.1g; Fatty-PF Group, 87.8g), but visceral fat
weight and V/S ratio in the Fatty-PF Group were decreased
as compared with those in the Fatty Group (mean value
of visceral fat weight or V/S ratio: Fatty Group, 47.9g or
1.29; Fatty-PF Group, 37.0g or 0.75; see Table 1, Figure 2).
Moreover, subcutaneous fat weight in the Fatty-PF Group
was increased as compared with that in the Fatty Group.
Similar changes were observed at 22 weeks of age, but the
changes were not signiﬁcant (Table 1).
In examination of intraperitoneal fat weight at 12 weeks
of age, epididymal and retroperitoneal fat weights in the
Fatty-PF Group were decreased at 12 weeks of age as
compared with those in the Fatty Group, whereas the
mesentericfatweightsbetweentwogroupswerenotchanged
(Table 2).
Food restriction in SDT fatty rats induced decreases of
visceral fat weight and V/S ratio.
3.3. Fat Cell Size. Fat cell size at 12 weeks of age in the Fatty
Group was about 2.3 times higher than that in the SDT
Group (mean ± SD: Fatty Group, 8059 ± 1967μm2;S D T
Group, 3553 ± 341μm2). The fat cell size in the Fatty-PF
Group (mean ± SD: 6080 ± 355μm2) tended to be decreased
by about 25% as compared with that in the SDT Group
(Figure 3).
Food restriction in SDT fatty rats induced a miniaturiza-
tion of the fat cell size.
3.4. Glucose Oxidation. Both basal glucose oxidation levels
and insulin-stimulated glucose oxidation levels in adipose
tissue of SDT fatty rats tended to be decreased as comparedExperimental Diabetes Research 5
(a)
(b)
(c)
Figure 2: Computed tomography analysis at 12 weeks of age
(representative tomogram). (a) Fatty rat; (b) fatty-PF rat; (c) SDT
rat.Yellow:subcutaneousfat;red:visceralfat;blue:lean.Visceralfat
area in fatty rat was decreased by food restriction.
with those in SDT rats (Figure 4), and especially in 100nM
insulin, the decrease of glucose oxidation in the Fatty Group
was signiﬁcant. Glucose oxidation levels in the Fatty-PF
Group were recovered to similar levels as in the SDT Group.
Food restriction in the SDT fatty rats induced improve-
ment of the metabolic function of adipose tissue.
3.5. mRNA Expression in Adipose Tissue. GLUT4 and ACC-
1 mRNA levels between the Fatty Group and the SDT Group
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Figure 3: Fat cell size in epididymal fat at 12 weeks of age. Fat cell
size in fatty rats was about 2.3 times higher than that in SDT rats.
Thefatcellsizetendedtodecreasebyabout25%byfoodrestriction.
Data represent means ± SD (n = 6). ∗∗P<. 01: signiﬁcantly
diﬀerent from SDT rat.
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Figure 4: Glucose oxidation levels in epididymal fat at 12 weeks
of age. The glucose oxidation levels were examined under basal-
(without insulin) or insulin-stimulated (0.1–100nM) conditions.
Insulin-stimulated glucose oxidation in fatty rats was deteriorated
as compared with that in SDT rats. The glucose oxidation level was
recovered by food restriction. Data represent means ± SD (n = 6).
∗P<. 05: signiﬁcantly diﬀerent from SDT rat.
werenotchanged,whereasthoselevelsintheFatty-PFGroup
were elevated as compared with that in the Fatty Group
(Figures 5(a) and 5(b)). LPL mRNA level in the Fatty Group
increased as compared with that in the SDT Group, and
the levels in the Fatty-PF Group were, furthermore, elevated
(Figure 5(c)). TNFα mRNA level in the Fatty Group tended
toincreaseascomparedwiththatintheSDTGroup,whereas
the levels between the Fatty Group and the Fatty-PF Group
were not changed (Figure 5(d)).6 Experimental Diabetes Research
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Figure 5: GLUT4 (a), ACC-1 (b), LPL (c) and TNFα (d) mRNA levels in epididymal fat at 12 weeks of age. All mRNA expressions were
measured by a real-time quantitative PCR method. The mRNA levels were corrected with 18 seconds rRNA. Data represent means ± SD
(n = 6). #P<. 05: signiﬁcantly diﬀerent from SDT fatty rat.
4. Discussion
SDT rat, which is a model of nonobese type 2 diabetes,
was established in 1997 by Shinohara et al. [2]. The rat
spontaneously develops hyperglycemia and glucose intoler-
ance resulting from decreased insulin secretion due to β-
cell degeneration [12]. Interestingly, SDT rat shows ocular
complications, such as venous dilation and meandering
vascular networks, which are caused by hyperglycemia [4].
It is also reported that SDT rat is useful as a model of
diabetic nephropathy [13]. More recently, Masuyama et al.
[1] produced an SDT fatty rat by introducing the fa allele
of the Zucker fatty rat into the SDT rat genome. SDT
fatty rats manifest hyperphagia, obesity, hyperglycemia, and
hyperlipidemia. The fatty rats develop diabetes from 5 weeks
of age, a development time that is quite earlier than for SDT
rats [5]. This early incidence or progression of diabetes is
considered to be caused by hyperphagia, which is associated
with a leptin signal abnormality induced by introduction of
the fa allele. In this study, we investigated the eﬀects of food
restriction on bloodchemical parameters and adipose tissue
in SDT fatty rats.
Under food restriction, body weights in the Fatty Group
were regulated to similar levels as those in the SDT Group
(Figure 1(a)). The rats in the Fatty-PF Group showed an
improvement of hyperglycemia and a tendency of TG levels
to be decreased at 12 weeks of age (Figures 1(b) and 1(c)).
These improvements in glucose and TG levels were also
reported under food-regulated conditions of Zucker diabetic
fatty rats [14] and by food restriction in OLETF rats [15].
Moreover, food restriction in normal rats (Wistar rats) did
not show a lowering eﬀect on fasting plasma glucose level,
whereas the fasting plasma insulin level decreased [16]. The
improvement in the Fatty-PF Group was not continuously
observed, and the elevation of glucose and TG levels was
observed at 22 weeks of age (Figures 1(b) and 1(c)). Since
SDT fatty rats might have weakness in pancreatic function
[1], it is considered that the insulin secretion is deteriorated,
andtheincidenceofdiabetesintheratscannotbesuppressed
by food restriction alone. Serum insulin level in the Fatty-
PF Group was decreased to a similar level in the SDT fatty
Group at 22 weeks of age (Figure 1(d)). Also, elevation of
TG levels at 22 weeks of age in the Fatty-PF Group is
consideredtobecausedbytheinsulindeﬁciency.Bothserum
leptin level and serum adiponectin level in SDT fatty ratsExperimental Diabetes Research 7
Table 2: Intraperitoneal fat tissue weights at 12 weeks of age. Data represent mean ± SD (n = 6).
Epididymal fat (g) Retroperitoneal fat (g) Mesenteric fat (g)
Fatty Group 14.6 ± 0.7 16.4 ± 1.4 10.9 ± 0.6
Fatty-PF Group 12.0 ± 1.8## 12.8 ± 1.7## 10.7 ± 0.9
SDT Group 6.8 ± 0.7 8.7 ± 1.0 5.5 ± 0.6
##P<. 01: signiﬁcantly diﬀerent from Fatty Group.
were increased by food restriction (Figures 1(e) and 1(f)).
It is reported that plasma leptin level was decreased, and
plasma adiponectin level was increased by food restriction
in Wistar rats and OLETF rats [15, 16] .T h ec h a n g ei n
adiponectin level was consistent with the result in our study,
but the change in leptin level was inconsistent with our
result. Since leptin resistance exists in SDT fatty rats, the
serum leptin level may not be decreased by food restriction.
Furthermore, the increase in serum leptin levels in food-
restricted SDT fatty rat is considered to be caused by the
increase of subcutaneous fat weight (Table 1). On the other
hand, the increase of serum adiponectin levels in food-
restricted SDT fatty rat is considered to be related to the
decrease of visceral fat weight. In the investigation on the
eﬀects of food restriction on biochemical parameters in SDT
fatty rats, a temporal improvement of hyperglycemia and
an increase of adipokine level were observed. Especially, the
improvement of hyperglycemia was partial, and the reason is
considered to be related with the background factor in SDT
rats.
In analysis of fat tissue weights in the pair-feeding
SDT fatty rat, the visceral fat or the V/S ratio signiﬁcantly
decreased, whereas the subcutaneous fat tended to increase
as compared with the SDT fatty rat (Table 1). It is reported
that total fat weight, including visceral fat and subcutaneous
fat, was decreased by food restriction in normal rats [16–
18], OLETF rats [15], and Zucker fatty rats [19]. The change
of visceral fat in our study was consistent with results in
some reports, but the change of subcutaneous fat mass in
our study was inconsistent with the some results. Those
changes of fat tissue weight in this study were similar
with changes after treatment with thiazolidinediones [20,
21]. After pioglitazone treatment, subcutaneous fat area
increased, whereas visceral fat area and the ratio of visceral
to subcutaneous fat decreased [20, 21]. In human obesity,
the contribution of abdominal visceral and subcutaneous
fat is widely noticed [22, 23]. There is a strong association
between visceral adiposity and insulin resistance patterns of
glucose homeostasis, including in type 2 diabetes mellitus
[24, 25]. Furthermore, visceral fat is related to essential
hypertension, dyslipidemia, and cardiovascular disease [26,
27]. Evaluation for the pattern of that fat distribution in
SDT fatty rat is considered to be very important to elucidate
pathophysiological features in human obesity.
According to CT analysis at 6, 12, and 22 weeks of
age, we showed signiﬁcant diﬀerence in the ratio of visceral
fat to subcutaneous fat at 12 weeks of age (Table 1). So
we investigated fat weight, fat cell size, glucose oxidation,
and quantiﬁcation of mRNA at this age. In examination of
intraperitoneal fat weight, epididymal and retroperitoneal
fat weights in the SDT fatty rats were decreased by food
restriction for 6 weeks, whereas the mesenteric fat weight
was not changed (Table 2). Epididymal and retroperitoneal
fatweightsinWistarratsandOLETFratshadbeendecreased
by food restriction [15, 16]. Furthermore, the mesenteric fat
weight in OLETF rats was lowered by the food restriction for
12 weeks. A decrease of mesenteric fat weight may not be
causedbyfoodrestrictionfor6weeks,whichwasacondition
in our study.
F a tc e l ls i z ei nt h eS D Tf a t t yr a tt e n d e dt od e c r e a s eb y
food restriction (Figure 3). It is reported that a decrease of
energy intake, that is, a restriction of food intake, induces
miniaturization of fat cells in Sprague-Dawley rats [28,
29]. In general, food restriction is considered to induce
an increase in the number of small adipocytes in rats.
Furthermore, it is reported that a miniaturization of fat
cell size induces increase of plasma adiponectin levels [30].
It is possible that the increase of serum adiponectin levels
in the pair-feeding rat (Figure 1(f)) was induced by the
miniaturization of fat cell size.
Insulin stimulated-glucose oxidation in the pair-feeding
SDT fatty rats was elevated as compared with that in the
SDTfattyrats(Figure 4),anditisconsideredthattheglucose
metabolic function in the SDT fatty rat was promoted
by food restriction. Glucose utilization index and glucose
metabolic index of retroperitoneal and epididymal adipose
tissues has been also increased in food-restricted Wistar
rats [16, 17]. Since it is reported that insulin stimulated-
glucose oxidation was elevated by a reinforcement of insulin
sensitivity[31],therecoveryofglucoseoxidationinthefood-
restricted SDT fatty rats may be caused by the improvement
of glicolipid abnormalities, such as the decrease of serum
glucose level and TG level (Figures 1(b) and 1(c)). Also,
increases of blood leptin level and adiponectin level are
considered to induce good eﬀects on the metabolic function
of adipose tissue [16, 32–35]. Furthermore, GLUT4, LPL,
and ACC mRNA expressions in the pair-feeding SDT fatty
rats increased (Figure 5). It is reported that these mRNA
expressionsinadiposetissueisincreasedbyinsulintreatment
[36, 37]. Since the serum insulin level in the pair-feeding
SDT fatty rats at 12 weeks of age increased (Figure 1(d)),
the elevation of these mRNA expressions is considered to be
induced by the increase of the insulin levels. Furthermore,
another reason for the elevation of these mRNA expressions
is considered to be reinforcement of insulin sensitivity
by food restriction (Figure 4). Decrease of TNFα mRNA
expression and increase of GLUT4 mRNA expression were
shown in treatment with thiazolidinediones [38, 39], but
the TNFα mRNA expression did not change in this study
(Figure 5(b)). Although this evaluation of adipose tissue was8 Experimental Diabetes Research
performed by using epididymal fats, the further examination
by using other adipose tissue might be essential. In the
investigation on the eﬀects of food restriction on adipose
tissue in SDT fatty rats, a decrease of visceral fat weight
and a miniaturization of the fat cell size were observed.
Moreover, the food restriction induced an improvement of
the metabolic function on adipose tissue.
Food restriction in SDT fatty rats partially improved the
glycolipid parameters and induced a decrease of the visceral
fat weight. Furthermore, the food restriction aﬀected the fat
cell size and the metabolic function in the adipose tissue. In
conclusion, SDT fatty rat is a useful model to evaluate the
functional or the morphological features in adipose tissue
and develop a novel drug for antiobesity.
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